These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23828830)

  • 21. Inappropriate therapy from a defibrillator complicating transcoronary ablation of septal hypertrophy in a patient with hypertrophic obstructive cardiomyopathy.
    Shah P; Harris L; Hill A; Schwartz L; Cameron D
    Pacing Clin Electrophysiol; 2004 May; 27(5):677-80. PubMed ID: 15125730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.
    Jensen MK; Prinz C; Horstkotte D; van Buuren F; Bitter T; Faber L; Bundgaard H
    Heart; 2013 Jul; 99(14):1012-7. PubMed ID: 23644300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertrophic obstructive cardiomyopathy and septal ablation.
    Steinbis S
    Crit Care Nurse; 2003 Jun; 23(3):47-50. PubMed ID: 12830780
    [No Abstract]   [Full Text] [Related]  

  • 24. Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.
    Jensen MK; Havndrup O; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
    Scand Cardiovasc J; 2011 Jun; 45(3):153-60. PubMed ID: 21604920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Kuhn H
    Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
    Chen SL; Ye F; Xu ZL; Lin S; Duan BX; Dai ZL; Shan SJ; Zhang JJ
    Chin Med J (Engl); 2006 Jul; 119(13):1121-4. PubMed ID: 16834933
    [No Abstract]   [Full Text] [Related]  

  • 27. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Faber L
    Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol Ablation in Hypertrophic Cardiomyopathy: Localization and Quantification of Target Septal Artery-dependent Myocardium With 3-Dimensional Echocardiography.
    Moya-Mur JL; Mestre-Barcelo JL; Salido-Tahoces L; Hinojar-Baydes R; Hernández-Antolín R; Zamorano-Gómez JL
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):531-3. PubMed ID: 25935148
    [No Abstract]   [Full Text] [Related]  

  • 29. Gelatin lights-agitated gelatin as an echocardiographic contrast agent for alcohol septal ablation.
    Bahl A; Barwad P; Paramasivam G
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S51-S53. PubMed ID: 27751327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A toast to no sternotomy.
    Yadav PK; Eng MH
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):960-961. PubMed ID: 27886454
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy].
    Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of alcohol septal ablation in patients with symptomatic concentric left ventricular hypertrophy and outflow tract obstruction.
    Kovacic JC; Khanna D; Kaplish D; Karajgikar R; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Dec; 22(12):586-91. PubMed ID: 21127363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early opening of dormant septal collaterals during alcohol septal ablation: a possible hazard of remote necrosis.
    Spacek M; Zemanek D; Tomasov P; Veselka J
    Can J Cardiol; 2013 Nov; 29(11):1531.e5-7. PubMed ID: 24054921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Amano Y; Takayama M; Amano M; Kumazaki T
    AJR Am J Roentgenol; 2004 Feb; 182(2):523-7. PubMed ID: 14736694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
    Seggewiss H; Faber L; Ziemssen P; Gleichmann U
    Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical versus alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the pendulum swings.
    Yacoub MH
    Circulation; 2005 Jul; 112(4):450-2. PubMed ID: 16043655
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effectivness of transcatheter alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy].
    Chernov SA; Kucherov VV; Fursov AN; Zakharova EG; Gaĭdukov AV; Liapkova NB; Korneev NV; Pestovskaia OR
    Voen Med Zh; 2009 Feb; 330(2):28-35. PubMed ID: 19351021
    [No Abstract]   [Full Text] [Related]  

  • 40. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
    J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.